Genome-wide Pol II and transcription factor mapping |
ChIP, ChIP-seq, ChIP-exo, ChIP-nexus |
Determination of the location of Pol II and its binding partners |
Genome-wide Pol II mapping |
Permanganate ChIP-seq, GRO-seq, PRO-seq, ChRO-seq, NET-seq, chromatin-associated nascent transcript sequencing |
Mapping of transcriptionally engaged Pol II |
Pol II mapping |
Nuclear walk-on assay |
Quantitative assessment of pausing |
Pol II mapping |
Reporter ChIP-nexus |
Evaluation of Pol II pausing on transfected plasmids |
Genome-wide Pol II and transcription factor mapping |
Drosophila polytene chromosome staining |
Observing association of Pol II and other factors such as NELF and DSIF with chromosomes |
Cell free |
Nuclear extract pausing assays |
Study of individual factors in semi in vivo conditions |
Cell free |
Electrophoretic mobility shift assay |
Examination of binding effectiveness between Pol II and pausing factors; useful for targeted mutagenesis studies of NELF and DSIF domains |
Cell free |
Reconstituted pausing assay using purified Pol II, DSIF, NELF. HSF1, and PIC components |
Potentially transformative for in vitro mutagenesis-function studies of pausing factors |
Drug |
Triptolide |
Inhibition of Pol II initiation; useful for estimates of Pol II pause half life |
Drug |
Flavopiridol, DRB, other P-TEFb inhibitors |
Inhibition of Pol II pause release |
Drug |
Pol II-DSIF inhibitors |
May provide significant insight into the role of DSIF in pausing |
Structural data |
Structures of Pol II-DSIF-NELF and Pol II-DSIF-Spt6-PAF |
Critical roadmaps for designing biochemical studies |